Log in

OTCMKTS:CVLBConversion Labs Stock Price, Forecast & News

-0.02 (-4.17 %)
(As of 07/8/2020 04:00 PM ET)
Today's Range
Now: $0.46
50-Day Range
MA: $0.32
52-Week Range
Now: $0.46
Volume649,700 shs
Average Volume288,542 shs
Market Capitalization$32.69 million
P/E RatioN/A
Dividend YieldN/A
Conversion Labs, Inc., an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; and PDF Simpli, a PDF conversion software. The company sells its products through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous manufacturing industries
Current SymbolOTCMKTS:CVLB



Sales & Book Value

Annual Sales$12.47 million
Book Value($0.02) per share


Net Income$-3,140,000.00


Market Cap$32.69 million
Next Earnings Date8/18/2020 (Estimated)
OptionableNot Optionable

Receive CVLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CVLB and its competitors with MarketBeat's FREE daily newsletter.

Conversion Labs (OTCMKTS:CVLB) Frequently Asked Questions

How has Conversion Labs' stock been impacted by COVID-19 (Coronavirus)?

Conversion Labs' stock was trading at $0.1269 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CVLB shares have increased by 262.5% and is now trading at $0.46. View which stocks have been most impacted by Coronavirus.

When is Conversion Labs' next earnings date?

Conversion Labs is scheduled to release its next quarterly earnings announcement on Tuesday, August 18th 2020. View our earnings forecast for Conversion Labs.

How were Conversion Labs' earnings last quarter?

Conversion Labs Inc (OTCMKTS:CVLB) posted its earnings results on Tuesday, May, 19th. The company reported ($0.05) earnings per share (EPS) for the quarter. The company had revenue of $4.31 million for the quarter. View Conversion Labs' earnings history.

Has Conversion Labs been receiving favorable news coverage?

Media headlines about CVLB stock have trended negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Conversion Labs earned a news impact score of -2.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Conversion Labs.

Who are some of Conversion Labs' key competitors?

What other stocks do shareholders of Conversion Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Conversion Labs investors own include AXT (AXTI), Alteryx (AYX), Notis Global (NGBL), Primo Water (PRMW), AVEO Pharmaceuticals (AVEO), Brookfield Infrastructure Partners (BIP), BP (BP), BP Prudhoe Bay Royalty Trust (BPT), Blackstone Mortgage Trust (BXMT) and Canopy Growth (CGC).

Who are Conversion Labs' key executives?

Conversion Labs' management team includes the following people:
  • Mr. Justin Schreiber, CEO, Pres & Director (Age 36)
  • Mr. Stefan Galluppi, COO, Chief Technology Officer & Director (Age 32)
  • Dr. Joseph V. DiTrolio, Chief Medical Officer of North America & Director (Age 68)
  • Mr. Robert Kalkstein, Advisor to the CEO (Age 37)
  • Mr. Sean Fitzpatrick, Chief Acquisition Officer (Age 36)

What is Conversion Labs' stock symbol?

Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLB."

How do I buy shares of Conversion Labs?

Shares of CVLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Conversion Labs' stock price today?

One share of CVLB stock can currently be purchased for approximately $0.46.

How big of a company is Conversion Labs?

Conversion Labs has a market capitalization of $32.69 million and generates $12.47 million in revenue each year. Conversion Labs employs 16 workers across the globe.

What is Conversion Labs' official website?

The official website for Conversion Labs is www.conversionlabs.com.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at 855-743-6478 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.